Is ABBV Worth Buying in 2026?

ABBVIE INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether ABBVIE INC. (ABBV) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.24% over 10 days); strong 1-year return of +18.4%. Currently 7.0% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

ABBV is in a confirmed uptrend, trading above both its 50-day ($210.80) and 200-day ($220.35) moving averages. An RSI of 65.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +18.4% compares to +22.9% for SPY (trailed the market by 4.5%).

$10,000 invested 1 year ago → $11,835 today
vs. S&P 500 (SPY) — same period trailed market by 4.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($220.35)
Above 50-day MA ($210.80)
RSI(14) neutral zone (30–70) — currently 65.7
Positive return (+18.4%)
Within 10% of period high (−7.0%)
Period Range $227.73
$181.73 $244.81
RSI (14) 65.7
0 · OversoldOverbought · 100

Key Metrics

Price$227.73
Period Return+18.4%
Period High$244.81
Period Low$181.73
Drawdown−7.0%
MA-50$210.80
MA-200$220.35
RSI (14)65.7
Avg Volume (30d)5.4M
vs. SPYtrailed by 4.5%
Return Rank#549 of 1246

Trade ABBV

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers